TITLE

Outcome of Penicillin-Susceptible Streptococcal Prosthetic Joint Infection Treated with Debridement and Retention of the Prosthesis

AUTHOR(S)
Meehan, A.M.; Osmon, D.R.; Duffy, M.C.T.; Hanssen, A.D.; Keating, M.R.
PUB. DATE
April 2003
SOURCE
Clinical Infectious Diseases;4/1/2003, Vol. 36 Issue 7, p845
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Debridement with retention of the prosthesis was the initial treatment modality for 19 cases of penicillin-susceptible streptococcal prosthetic joint infection that occurred in 18 patients who presented to the Mayo Clinic (Rochester, Minnesota) during 1969-1998. All of the cases of prosthetic joint infection occurred >30 days after implantation of the prosthesis, which was well fixed at the time of debridement. The median duration of symptoms before debridement was 4 days (range, 1-10 days). Treatment failure (defined as relapse of infection with the original microorganism) occurred in 2 cases (10.5%) during a median follow-up period of 3.9 years (range, 0.3-21.7 years). The 1-year cumulative risk of relapse was 11% (95% confidence interval, 0%-26%). Relapse of prosthetic joint infection due to penicillin-susceptible streptococci after debridement and retention of the prosthesis is uncommon. For patients who present with a well-fixed prosthesis and a short duration of symptoms, debridement with retention appears to be an effective treatment modality.
ACCESSION #
9423827

 

Related Articles

  • Relative Neutralizing Activity in Polyspecific IgM, IgA, and IgG Preparations against Group A Streptococcal Superantigens. Norrby-Teglund, Anna; Ihendyane, Nahla; Kansal, Rita; Basma, Hesham; Kotb, Malak; Andersson, Jan; Hammarstrom, Lennart // Clinical Infectious Diseases;11/1/2000, Vol. 31 Issue 5, p1175 

    Presents a study that compared the ability of different immunoglobulin (Ig) preparations containing IgG, IgM and IgA to neutralize the activity of streptococcal pyrogenic exotoxin A or culture supernatant from a clinical group A streptococcal isolate. Causes of streptococcal infections;...

  • Deadly bacteria set off nationwide scare. Wickelgren, Ingrid // Current Science;10/21/94, Vol. 80 Issue 4, p8 

    Focuses on the infection cause by streptococcus A bacteria. Symptoms; Treatment with bacteria-killing drugs called antibiotics; Effects of the bacteria on children.

  • Signs of toxic strep.  // Current Science;10/21/94, Vol. 80 Issue 4, p9 

    Offers advice on ways to treat toxic strep. Washing of wounds; Application of antibacterial ointment to prevent infection; Symptoms of toxic strep infection.

  • TREATING INFECTIONS IN PREGNANT PATIENTS. Litwa, Wally; Mishell Jr., Daniel R. // Cortlandt Forum;9/25/2003, Vol. 16 Issue 9, p45 

    Discusses the preferred treatment for bacterial vaginosis and group B streptococcal infection during the first trimester of pregnancy. Symptoms of the disease; Means of treating group B stretococci colonized in the vagina or cervix; Prevention of infection in the neonate.

  • Rheumatic Fever and the Streptococcus--An Elegant Inquiry. J.R.E.; E.J.H. // Annals of Internal Medicine;Mar64, Vol. 60 Issue 3, p530 

    Editorial. Presents findings included in the papers under the common title of 'Rheumatic Fever in Children and Adolescents: A Long-Term Epidemiologic Study of Subsequent Prophylaxis, Streptococcal Infections and Clinical Sequelae,' published in the February 1964 issue of the 'Annals of Internal...

  • When ASO titers remain high. M.O.R. // Cortlandt Forum;8/25/96, Vol. 9 Issue 8, p58 

    Presents a response to the query regarding the duration of penicillin injections in a patient with persistent elevated antistreptolysin-O (ASO) titers in the United States. Dependence of the therapy duration on the nature of the streptococcal infection.

  • Consider cefixime for treating adult contacts of patients with group A strep.  // Modern Medicine;Apr96, Vol. 64 Issue 4, p57 

    Presents an abstract of the article entitled `Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci,' by H.D. Davies, D.E. Low, B. Schwartz which was published in the November 1995 issue of `Clinical Infectious Diseases.'

  • Short treatment for strep throat.  // Pediatrics for Parents;1999, Vol. 18 Issue 3, p11 

    Discusses the efficacy of the Omnicef antibiotic for treating strep throat. Bacteria that causes the disease; Efficacy of Omnicef versus penicillin.

  • CLARITHROMYCIN vs PENICILLIN. Hakkarinen, William D. // Journal of Family Practice;May93, Vol. 36 Issue 5, p485 

    A letter to the editor is presented in response to the article "Clarithromycin vs Penicillin in the Treatment of Streptococcal Pharyngitis," by C. G. Schrock in the 1992 issue.

  • CLARITHROMYCIN vs PENICILLIN. Luger, Steven W. // Journal of Family Practice;May93, Vol. 36 Issue 5, p485 

    A response by C. G. Schrock to a letter to the editor about his article "Clarithromycin vs Penicillin in the Treatment of Streptococcal Pharyngitis" in the 1992 issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics